EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fractional CO2 Laser in Lichen Sclerosus: A Dual Mechanism for Combination Therapy

Alessandro Clementi, Giovanni Cannarozzo, Luca Guarino, Elena Zappia, Marco Gratteri, Antonio Alma, Mario Sannino, Luca Gargano, Annunziata Dattola, Steven Paul Nisticò

Bioengineering · 11.11.2026 · 13 (11) · 1334

DOI: 10.3390/bioengineering13111334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioengineering, online erschienen am 11.11.2026. Verfasst von Alessandro Clementi und 9 weiteren Autor:innen. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lichen sclerosus is a chronic inflammatory dermatosis with anogenital predilection and a recognized risk of malignant transformation. Ultrapotent topical corticosteroids remain the standard of care, yet a clinically relevant proportion of patients shows partial response, early recurrence, or corticosteroid intolerance. Ablative fractional CO2 laser has been increasingly investigated as a second-line option, with growing clinical evidence supporting its efficacy on symptomatic and quality-of-life outcomes. This narrative review examines the mechanistic basis and the clinical evidence for fractional CO2 laser in lichen sclerosus. It sets out a dual-mechanism framework. Preclinical and histological studies show an intrinsic biological effect on the skin. This includes neocollagenesis, neoangiogenesis, local immunomodulation and re-epithelialization of atrophic tissue. The same treatment also increases the cutaneous delivery of co-applied topical agents through laser-assisted drug delivery. These two mechanisms support combining fractional CO2 laser with topical corticosteroids as an add-on strategy, rather than a head-to-head alternative to the standard of care. Current evidence is reviewed across monotherapy and combination protocols, alongside the largely unexplored male form of the disease, and further comparative studies are needed to confirm this rationale.

Zitieren

APA

Clementi, A., Cannarozzo, G., Guarino, L., Zappia, E., Gratteri, M., Alma, A., Sannino, M., Gargano, L., Dattola, A., & Nisticò, S. P. (2026). Fractional CO2 Laser in Lichen Sclerosus: A Dual Mechanism for Combination Therapy. Bioengineering, 13(11), 1334. https://doi.org/10.3390/bioengineering13111334

Vancouver

Clementi A, Cannarozzo G, Guarino L, Zappia E, Gratteri M, Alma A, et al. Fractional CO2 Laser in Lichen Sclerosus: A Dual Mechanism for Combination Therapy. Bioengineering. 2026;13(11):1334. doi:10.3390/bioengineering13111334

BibTeX
@article{Clementi2026,
  author = {Clementi, Alessandro and Cannarozzo, Giovanni and Guarino, Luca and Zappia, Elena and Gratteri, Marco and Alma, Antonio and Sannino, Mario and Gargano, Luca and Dattola, Annunziata and Nisticò, Steven Paul},
  title = {Fractional CO2 Laser in Lichen Sclerosus: A Dual Mechanism for Combination Therapy},
  journal = {Bioengineering},
  year = {2026},
  volume = {13},
  number = {11},
  pages = {1334},
  doi = {10.3390/bioengineering13111334}
}
Kostenlos starten →